Opaleye Management Inc.
Top Portfolio Positions
53 positions ·
$763,048,828 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| HROW |
Harrow, Inc.
Healthcare
|
2,832,230 | $99,864,429 | 13.09% | |
| LQDA |
Liquidia Corp
Healthcare
|
2,545,000 | $96,048,300 | 12.59% | |
| ETON |
Eton Pharmaceuticals, Inc.
Healthcare
|
2,860,000 | $70,584,800 | 9.25% | |
| SLGL |
Sol-Gel Technologies Ltd.
Healthcare
|
500,000 | $39,610,000 | 5.19% | |
| RZLT |
Rezolute, Inc.
Healthcare
|
12,600,000 | $38,430,000 | 5.04% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
390,000 | $32,826,300 | 4.30% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
421,000 | $26,918,740 | 3.53% | |
| URGN |
UroGen Pharma Ltd.
Healthcare
|
1,430,000 | $25,711,400 | 3.37% | |
| CBIO |
Crescent Biopharma, Inc.
Healthcare
|
1,312,615 | $24,112,737 | 3.16% | |
| STOK |
Stoke Therapeutics, Inc.
Healthcare
|
700,000 | $22,792,000 | 2.99% |
Portfolio Trend
25 quarters · across all stocks
Holdings in CDXS
Shares Held
Position Value (USD)
27 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,059,550 | 6,785,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $11,067,272 | 6,789,738 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $11,067,272 | 6,789,738 | Shares | Sole | 2026-01-23 | |
| 2025-12-03 | $15,189,701 | 8,987,989 | Shares | Sole | 2025-12-05 | |
| 2025-09-30 | $31,219,800 | 12,795,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $30,744,000 | 12,600,000 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $25,555,000 | 9,500,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $42,166,800 | 8,840,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $27,011,600 | 8,770,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,710,500 | 3,455,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $10,888,800 | 3,120,000 | Shares | Sole | 2024-05-29 | |
| 2023-12-31 | $9,288,851 | 3,045,525 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,114,721 | 1,118,900 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $1,890,000 | 675,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,105,000 | 750,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,461,950 | 957,500 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $6,999,300 | 1,155,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $13,477,187 | 1,288,450 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $27,733,900 | 1,345,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $42,058,150 | 1,345,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $31,284,700 | 1,345,000 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $30,477,700 | 1,345,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $32,046,000 | 1,400,000 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $30,562,000 | 1,400,000 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $16,436,000 | 1,400,000 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $15,960,000 | 1,400,000 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $15,624,000 | 1,400,000 | Shares | Sole | 2020-05-15 | |
| No 13F history on record for this holder in this stock. | ||||||